PTGS2 and neoplasm: Sixty-eight percent of positive cases (17 of 25) occurred in the 40–69 age group, only (16.7%) one of the six tumours in the 20–29 age category over-expressed COX-2, while 50% of the six cases in the age group 70–79 were positive (Table 4).